We are live on ! Find out more
BRNS

Barinthus Biotherapeutics
BRNS

15 hedge funds and large institutions have $10.4M invested in Barinthus Biotherapeutics in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.55% less ownership

Funds ownership: 23.08% → 22.53% (-0.55%)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$37.5K
2
+$25.2K
3
+$16.3K
4
Morgan Stanley
Morgan Stanley
New York
+$113
5
UBS Group
UBS Group
Switzerland
+$16

Top Sellers

1
-$106K
2
-$92.5K
3
-$14.8K
4
NECFA
New England Capital Financial Advisors
Connecticut
-$42
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.2M
2
$1.96M
3
$1.89M
4
$803K
5
$153K
6
$134K
7
$82.9K
8
$46.8K
9
$25K
10
$19K
11
$16.3K
12
$14.5K
13
$6.18K
14
$16
15
$1
16
–
17
–
18
–